Novartis drugs fail to help high-risk patients | Reuters

Links shared publicly online about this topic.

  • 1,315
    total visits

Novartis drugs fail to help high-risk patients | Reuters

feeds.reuters.com

ATLANTA (Reuters) - The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and heart disease, according

View full resource at feeds.reuters.com

Tags: Heart, Heart Disease, Coronary Artery Disease, Diabetes, Diabetes Medication, Disease and Condition, Drug, Novartis

  • Share

Most Recently Shared on March 14, 2010 at 2:03 pm By:

HITpol HealthIT Policy

Novartis drugs fail to help high-risk patients: ATLANTA (Reuters) - The Novartis diabetes drug Starlix failed to r... http://bit.ly/dcdroq

2 years ago...

Novartis drug fails to help after heart attack: study | Reuters

reuters.com — “ATLANTA (Reuters) - The addition of the Novartis blood pressure medicine Tekturna to current standard drugs in patients who had a heart attack failed to help prevent changes in the heart's shape and worseningView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 16, 2010 at 7:45 pm By:

hrana Hisham Rana, MD Doctor and Physician

Study: Novartis drug Tekturna fails to help after heart attack http://bit.ly/9YuBkd - From American College of Cardiology meeting. #health

2 years ago...

Novartis drug fails to help after heart attack: study | Reuters

feeds.reuters.com — “ATLANTA (Reuters) - The addition of the Novartis blood pressure medicine Tekturna to current standard drugs in patients who had a heart attack failed to help prevent changes in the heart's shape and worseningView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on March 16, 2010 at 12:12 pm By:

Reuters_Health Reuters Health Health News

Novartis drug fails to help after heart attack: study http://link.reuters.com/wuv93j

2 years ago...

Novartis drug fails to help after heart attack: study | Reuters

feeds.reuters.com — “ATLANTA (Reuters) - The addition of the Novartis blood pressure medicine Tekturna to current standard drugs in patients who had a heart attack failed to help prevent changes in the heart's shape and worseningView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on March 16, 2010 at 12:11 pm By:

HITpol HealthIT Policy Health News and Health IT

Novartis drug fails to help after heart attack: study: ATLANTA (Reuters) - The addition of the Novartis blood pres... http://bit.ly/byx0yI

2 years ago...

Novartis drug fails to help after heart attack: study | Reuters

reuters.com — “ATLANTA (Reuters) - The addition of the Novartis blood pressure medicine Tekturna to current standard drugs in patients who had a heart attack failed to help prevent changes in the heart's shape and worseningView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 16, 2010 at 12:11 pm By:

HealthNews2 Health News Health News

Novartis drug fails to help after heart attack: study: ATLANTA (Reuters) - The addition of the Novart... http://bit.ly/9USnie #health #news

2 years ago...

Novartis drugs fail to help high-risk patients

uk.mobile.reuters.com — “Novartis drugs fail to help high-risk patientsView full resource at uk.mobile.reuters.com

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 2:35 am By:

Novartis drugs fail to help high-risk patients - Yahoo! News

us.rd.yahoo.com — “The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and heart disease, according to a large study released on Sunday.View full resource at us.rd.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 14, 2010 at 2:19 pm By:

HealthNewsNow Health News Now Health News

Novartis drugs fail to help high-risk patients (Reuters) http://bit.ly/bqw5ZU

2 years ago...

Novartis drugs fail to help high-risk patients | Reuters

feeds.reuters.com — “ATLANTA (Reuters) - The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and heart disease, accordingView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on March 14, 2010 at 2:03 pm By:

Advertisement